Philipp Mann
5PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 17, 2026
Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study.Isabel Leroux-Roels, Ilse De Coster, Alberto M Borobia
|Nov 28, 2024
Enhanced and sustained biodistribution of HIV-1 neutralizing antibody VRC01LS in human genital and rectal mucosa.Maria P Lemos, Rena D Astronomo, Yunda Huang
|Oct 18, 2024
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.Brandon J Essink, Craig Shapiro, Marie Grace Dawn Isidro
|Apr 27, 2024
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity.Olaf-Oliver Wolz, Dominik Vahrenhorst, Gianluca Quintini
|Apr 23, 2022
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant.Olaf-Oliver Wolz, Sarah-Katharina Kays, Helga Junker
Pageof 1
Frequent Collaborators
3 joint publications
Olaf-Oliver Wolz
2 joint publications
Sven D Koch
1 joint publications
Michael Fehlings
1 joint publications
Jana Heß
1 joint publications
Lidia Oostvogels
1 joint publications
Brandon J Essink
1 joint publications
Marie Grace Dawn Isidro
1 joint publications
Mark Bloch
1 joint publications
Joel Santiaguel
1 joint publications
Melchor Victor Frias
